{
  "title": "Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer",
  "url": "https://ascopubs.org/doi/10.1200/OA-25-00051",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: 67% patient adherence to PRO assessments improved trial retention by 40%."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Integrate AI-driven reminders for optimal completion timing."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: Growing regulatory pressure mandates PRO integration in drug development."
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Self-selection bias may undermine the clinical validity of self-reported outcomes."
    }
  ],
  "model": "granite4:tiny-h"
}